CD44 and non-small cell lung carcinoma: It has been reported that SPP1/CD44 signaling in the glioma perivascular niche promotes aggressive tumor growth (Wei et al., 2019), and ITGB1 was related to the dismal OS in NSCLC (Zheng et al., 2016).